Equity
-€85,780
Debts exceed assets in financial year 2025.
PECUSO
Lifetime
1 annual account with figurespeak -€48,837 (2025)
-€48,837
lowest -€95,780 (2025)
-€95,780
peak -€85,780 (2025)
-€85,780
€182,596
Board2 names since 2023
2 directors and 1 other
Documentsfilings and deeds
11-02-202611 days late
2025micro format
Loss of €95,780Purpose change 11-04First year with figures
Key points
from the 2025 annual accountsDebts
€182,596 189% of the balance sheet
Financial debts 31%Suppliers 18%Taxes and wages 15%Other 35%
Of this, €125,224 falls due within a year.
Position in the sector
-€95,780
Lower net result than 95% of companies in wholesale trade. Sector median €5,135 · 15,425 companies.
2025 accounts filed 11 days after the deadlineTurnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 7,637 companies had the same profile as PECUSO has now. Each dot stands for 20 companies, two years later.
84.7%
were still trading
5.6%
stopped another way
8.9%
went bankrupt
Another 0.8% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,637 companies, not a prediction for PECUSO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director
- 10 sharesdeed of 11-12-2023
- 40 sharesdeed of 11-12-2023
- 50 sharesdeed of 11-12-2023
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1003092836
Purpose change
“Het aanbieden van hoogwaardige huidverbeteringsdiensten, waaronder maar niet beperkt tot…” (deed in Dutch) · Gazette deed
Incorporation
Founding capital of €5,000, 100 shares · Founders: , and · Appointments: (director) and (director) · published on 11-12-2023 · Gazette deed
First establishment
Populierenlaan 46, Lanaken
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PECUSO Lanaken | €96,815 | -€48,837 | -88.6% | - |
| CERDAK Lanaken | €103,436 | -€45,265 | -46.9% | - |
| Kolibrie Veterinair Distributiecentrum Beringen | €56,858 | -€8,589 | -14.4% | - |
| BTL Belgium Kontich | €136,557 | -€40,179 | -157.7% | - |
| DOCA-PHARMA Sint-Niklaas | €72,384 | -€27,380 | -110.2% | - |
| QS Supplements Edegem | €91,588 | -€39,686 | -100.5% | - |
| Medicode Antwerp | €63,460 | -€8,402 | 57.2% | - |
These companies have the same main activity as PECUSO: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €56,900 and €137,000, founded between 2022 and 2024.
Official details
Source: KBO- Status
- Active since 07-12-2023Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 2 others
- Establishment unit
- 2.355.327.8683621 Lanaken, since 07-12-2023
- Financial year end
- 30 June
- Peppol
- Reachable since 26-09-2025
Insights on PECUSO
The 2025 annual accounts show negative equity (-€85,780) and a net result of -€95,780. Its solvency ranks better than 9% of 15,428 sector peers (NACE 46, financial year 2025).
The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PECUSO
- What is the company number of PECUSO?
- The company number of PECUSO is 1003.092.836. The VAT number is the same number with BE in front: BE 1003.092.836.
- Where is PECUSO based?
- The registered office is at Steegstraat 50, 3620 Lanaken.Company details
- What does PECUSO do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of PECUSO?
- PECUSO is a private limited company (BV).
- When was PECUSO founded?
- PECUSO was founded on 07-12-2023.
- Is PECUSO still active?
- Yes, PECUSO is an active enterprise in the KBO register.
- What is the turnover of PECUSO?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is PECUSO profitable?
- In financial year 2025, PECUSO made a loss of €95,780.
- Where can I find the annual accounts of PECUSO?
- PECUSO filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.